Iin Kurnia Hasan Basri

Iin Kurnia Hasan Basri

Auto-generated profile, based on publicly available information

Iin Kurnia Hasan Basri

Research Center for Radioisotope, Radiopharmaceutical, and Biodosimetry Technology, Research Organization for Nuclear Energy, National Research and Innovation Agency

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Journal of Environmental Radioactivity
Verified
Journal Article
Closed access
IBIin Kurnia Hasan Basri
Iin Kurnia Hasan Basri
DYDarlina Yusuf
Darlina Yusuf
TRTur Rahardjo
Tur Rahardjo
SNSiti Nurhayati
Siti Nurhayati
DTDevita Tetriana
Devita Tetriana
MSMukh Syaifudin
Mukh Syaifudin

1 December 2014 in HAYATI Journal of Biosciences
Verified
Journal Article
Open access
PDF file
IKIin Kurnia
Iin Kurnia
BSBudiningsih Siregar
Budiningsih Siregar
SSSetiawan Soetopo
Setiawan Soetopo
IRIrwan Ramli
Irwan Ramli
TKTjahya Kurjana
Tjahya Kurjana
DTDevita Tetriana
Devita Tetriana
Akt is a protein that is associated with cell proliferation and is expressed at high levels in cancer cells. Some research indicates it may play a role in increasing the resistance of cancer cells to chemotherapy treatment. P53 is a tumor suppressor protein that influences the cell cycle and apoptosis. The purpose of this study was to examine the relationship between the expression of Akt and p53 in cancerous tissue before chemoradiation treatment, and the clinical response to treatment of cervical cancer patients. Twenty microscopic tissue samples were taken from cervical cancer biopsies obtained from patients before cancer treatment. The tissue samples were stained with p53 and Akt antibodies via immunohistochemistry technique, to measure expression of both proteins. After completion of chemoradiotherapy, patients’ clinical response to treatment was determined using the pelvic control method. Our results revealed no correlation between expression of Akt and p53 index (P = 0.74) as well as between p53 Index and chemoradiotherapy clinical response (P=0.29). There was significant correlation between expression of Akt and cervical cancer chemoradiotherapy response (P = 0.03). There was no correlation found between p53 index and chemoradiotherapy clinical response (P = 0.29). High expression of Akt may related with high cell proliferation and resistance to chemoradiotherapy.

2 October 2018 in Indonesian Journal of Cancer
Verified
Journal Article
Open access
PDF file
AMArifin Musthafa
Arifin Musthafa
FDFielda Djuita
Fielda Djuita
IKIin Kurnia
Iin Kurnia
Background: Exposure ionizing of radiation in radiation workers has the potential to cause DNA damage in the form of double strand break as the beginning of genomic instability. DNA damage can be observed with γ-H2AX as the biomarker of DNA double strand breaks (DSBs). The formation of γ-H2AX in the nucleus can occur after radiation exposure of 1 mGy. This study aims to determine the radiation effects in radiation work environments as a study of adaptive responses of peripheral blood mononuclear cell (PBMCs) after radiation by observing γ-H2AX foci expression.. Methods: Blood samples from nine radiation workers and nine non-radiation workers were irradiated with doses 0 Gy, 1 Gy, 1.5 Gy, and 2 Gy. Detection of γ-H2AX foci was done by immunofluorescence assay. The mean of γ-H2AX foci was counted in 50 PBMCs per sample. The comparison mean of γ-H2AX foci was analyzed using tindependent test. Result: Based on the result study, there were no significant differences in the number of γ-H2AX foci without treatment (p = 0.807). The results of study showed that the formation of 2-3 foci per cell after exposure of 2 Gy increases along with the increasing irradiation doses. Conclusion: The mean of index of γ-H2AX foci in PBMCs within normal limits between non-radiation workers and radiation workers and level of risk DSBs damage is relatively similar after exposure at doses 1 Gy, 1.5 Gy, and 2 Gy.

7 January 2026 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
HSHarry Surniyantoro
Harry Surniyantoro
APAndhika Yudha Prawira
Andhika Yudha Prawira
FFFadhillah Fadhillah
Fadhillah Fadhillah
RLRetno Lestari
Retno Lestari
IBIin Kurnia Hasan Basri
Iin Kurnia Hasan Basri
MSMukh Syaifudin
Mukh Syaifudin
This study aimed to investigate oxidative stress and histopathological changes in healthy rats after oral administration of I-131, to elucidate the mechanisms of gastrointestinal mucosal injury associated with radioiodine exposure, and provide translational insights relevant to clinical radioiodine therapy. Twenty-seven rats received I-131 (9.62 × 106 Bq/100 µL) orally. Observations were made up to 7 days post-administration. Oxidative stress levels in the thyroid, small intestine, and stomach were measured using an enzyme-linked immunosorbent assay, while histopathological changes were analyzed using hematoxylin-eosin staining. Data were analyzed using one-way analysis of variance (SPSS v25). Biochemical assays showed mild and inconsistent variations in antioxidant enzyme activity. H2O2 levels remained stable, whereas thyroid SOD activity exhibited a transient ∼22-fold increase within the first hour before returning to baseline by day 7, with no corresponding elevation in CAT or GPx. Histopathological evaluation revealed marked mucosal injury in the small intestine, characterized by epithelial erosion, edema, and inflammatory infiltration within 30 min, peaking at 2-3 h, and partially reappearing on days 5-7. In contrast, gastric lesions were milder and resolved completely by day 7. The discrepancy between biochemical stability and pronounced tissue injury suggests that localized oxidative stress may occur despite unchanged bulk reactive oxygen species levels, likely due to rapid compensatory antioxidant responses in healthy tissues. Overall, these findings underscore the importance of integrating biochemical and histological endpoints for a comprehensive assessment of radiation-induced toxicity. This integrated approach also supports further investigation into lipid peroxidation, protein oxidation, glutathione redox status, and mitochondrial function to elucidate the mechanisms underlying radioiodine-induced oxidative stress.

16 January 2025 in Pharmacia
Verified
Journal Article
Open access
PDF file
DPDian Pribadi Perkasa
Dian Pribadi Perkasa
IKIin Kurnia
Iin Kurnia
TFTaufik Muhammad Fakih
Taufik Muhammad Fakih
TKTeja Kisnanto
Teja Kisnanto
DRDwi Ramadhani
Dwi Ramadhani
MSMukh Syaifudin
Mukh Syaifudin
The radioprotective potential of Sitahe (Leuconotis eugenifolia) phytochemicals in cancer radiotherapy remains largely unexplored. In this study, in silico docking simulations were conducted to systematically assess the ability of key phytochemicals from Sitahe to modulate p53 activity, a critical gene in DNA repair and cancer therapy. SwissADME analysis revealed favorable physicochemical properties for compounds such as baurenol, alpha amyrin, and beta amyrin, although high lipophilicity may pose challenges for bioavailability. Molecular docking studies identified strong binding affinities between these compounds and the p53 DNA binding domain, with baurenol demonstrating the highest binding affinity at −6.75 kcal/mol, which is better compared to rhazinilam (−4.55 kcal/mol), leuconolam (−4.36 kcal/mol), leuconoxine (−4.26 kcal/mol), and dehydroleuconoxine (−4.76 kcal/mol). Hydrogen bonding with key residues such as Thr123 further enhanced the stability of these complexes. The low inhibition constants (Ki) suggest significant inhibitory potential, particularly for baurenol (11.31 μM). To evaluate the stability and reliability of these interactions, molecular dynamics (MD) simulations were performed over a duration of 500 ns. The results demonstrated that the selected compounds maintained stable molecular dynamics profiles, showing consistent interactions with the target protein throughout the simulation period. Among the compounds tested, baurenol exhibited the best performance with a MM/PBSA binding energy of −68.568 kJ/mol, which is better than rhazinilam (−63.538 kJ/mol). These findings suggest that baurenol, along with other Sitahe phytochemicals, could serve as dual-function agents, offering protection to healthy tissues from radiation-induced damage while targeting cancer cells through p53 modulation. Although these in silico and MD results are promising, further validation through in vitro and in vivo studies is essential to confirm their therapeutic potential and optimize their pharmacokinetic properties. This study positions Sitahe phytochemicals, particularly baurenol, as promising candidates for the development of novel radioprotective agents in cancer treatment.

Verified
Conference Paper
Closed access
IBIin Kurnia Hasan Basri
Iin Kurnia Hasan Basri
FAFajriansyah
Fajriansyah
BSBudiningsih Siregar
Budiningsih Siregar
BHBethy Suryawathy Hernowo
Bethy Suryawathy Hernowo